Skip to main content
Top
Published in: Pediatric Rheumatology 1/2016

Open Access 01-12-2016 | Research article

Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography

Published in: Pediatric Rheumatology | Issue 1/2016

Login to get access

Abstract

Background

Dystrophic calcifications may occur in patients with J uvenile Idiopathic Inflammatory Myopathy (JIIM) as well as other connective tissue and metabolic diseases, but a reliable method of measuring the volume of these calcifications has not been established. The purpose of this study is to determine the feasibility of low dose, limited slice, Computed Tomography (CT) to measure objectively in-situ calcification volumes in patients with JIIM over time.

Methods

Ten JIIM patients (eight JDM, two Overlap) with calcifications were prospectively recruited over a 2-year period to undergo two limited, low dose, four-slice CT scans. Calculation of the volume of calcifications used a CT post processing workstation. Additional patient data included: Disease Activity Scores (DAS), Childhood Myositis Assessment Scale (CMAS), myositis specific antibodies (MSA), and the TNFα-308 promoter region A/G polymorphism. Statistical analysis utilized the Pearson correlation coefficient, the paired t-test and descriptive statistics.

Results

Ten JIIM, mean age 14.54 ± 4.54 years, had a duration of untreated disease of 8.68 ± 5.65 months  MSA status: U1RNP (1), PM-Scl (1), Ro (1, 4 indeterminate), p155/140 (2), MJ (3), Mi-2 indeterminate (1), negative (3). 4/8 JDM (50%) were TNF-α-308 A+. Overall, the calcification volumes tended to decrease from the first to the second CT study by 0.5 cm3 (from 2.79 ± 1.98 cm3 to 2.29 ± 2.25 cm3). The average effective radiation dose was 0.007 ± 0.002, 0.010 ± 0.005, and 0.245 mSv for the upper extremity, lower extremity and chest, respectively (compared to a standard chest x-ray-- 0.02mSV effective dosage).

Conclusion

We conclude: 1) the limited low dose CT technique provides objective data about volume of the calcifications in JIIM; 2) measuring the volume of calcifications in an extremity is associated with minimal radiation exposure; 3) This method may be useful to evaluate the efficacy of therapies for JIIM dystrophic calcification.
Literature
1.
go back to reference Faller G, Mistry BJ, Tikly M. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014;12:2.CrossRefPubMedPubMedCentral Faller G, Mistry BJ, Tikly M. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014;12:2.CrossRefPubMedPubMedCentral
2.
go back to reference Pachman LM, Morgan GA, Curran ML, et al. Decreased frequency of dystrophic calcifications in children with juvenile dermatomyositis: a 10-year study [abstract]. Arthritis Rheum. 2012;64 Suppl 10:301. Pachman LM, Morgan GA, Curran ML, et al. Decreased frequency of dystrophic calcifications in children with juvenile dermatomyositis: a 10-year study [abstract]. Arthritis Rheum. 2012;64 Suppl 10:301.
3.
go back to reference Hoeltzel MF, Oberle EJ, Robinson AB, et al. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep. 2014;16(12):467.CrossRefPubMedPubMedCentral Hoeltzel MF, Oberle EJ, Robinson AB, et al. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep. 2014;16(12):467.CrossRefPubMedPubMedCentral
4.
go back to reference Shahi V, Wetter DA, Howe BM, et al. Plain radiography is effective for the detection of calcinosis cutis occurring in association with autoimmune connective tissue disease. Br J Dermatol. 2014;170(5):1073–9.CrossRefPubMed Shahi V, Wetter DA, Howe BM, et al. Plain radiography is effective for the detection of calcinosis cutis occurring in association with autoimmune connective tissue disease. Br J Dermatol. 2014;170(5):1073–9.CrossRefPubMed
5.
go back to reference Nazir L, Saeed M. The calcium invasion: calciphylaxis in Lupus. J Pak Med Assoc. 2015;65(4):427–8.PubMed Nazir L, Saeed M. The calcium invasion: calciphylaxis in Lupus. J Pak Med Assoc. 2015;65(4):427–8.PubMed
6.
go back to reference Tristano AG, Villarroel JL, Rodriguez MA, et al. Calcinosis cutis universalis in a patient with systemic lupus erythematosus. Clin Rheumatol. 2006;25(1):70–4 [Published Online First: 18 May 2005].CrossRefPubMed Tristano AG, Villarroel JL, Rodriguez MA, et al. Calcinosis cutis universalis in a patient with systemic lupus erythematosus. Clin Rheumatol. 2006;25(1):70–4 [Published Online First: 18 May 2005].CrossRefPubMed
7.
go back to reference Blane CE, White SJ, Braunstein EM, et al. Patterns of calcification in childhood dermatomyositis. AJR Am J Roentgenol. 1984;142(2):397–400.CrossRefPubMed Blane CE, White SJ, Braunstein EM, et al. Patterns of calcification in childhood dermatomyositis. AJR Am J Roentgenol. 1984;142(2):397–400.CrossRefPubMed
8.
go back to reference Bar-Sever Z, Mukamel M, Harel L, et al. Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99 m MDP. Clin Nucl Med. 2000;25(12):1013–6.CrossRefPubMed Bar-Sever Z, Mukamel M, Harel L, et al. Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99 m MDP. Clin Nucl Med. 2000;25(12):1013–6.CrossRefPubMed
9.
go back to reference Sarmiento AH, Alba J, Lanaro AE, et al. Evaluation of soft-tissue calcifications in dermatomyositis with 99mTc-phosphate compounds: case report. J Nucl Med. 1975;16(6):467–8.PubMed Sarmiento AH, Alba J, Lanaro AE, et al. Evaluation of soft-tissue calcifications in dermatomyositis with 99mTc-phosphate compounds: case report. J Nucl Med. 1975;16(6):467–8.PubMed
10.
go back to reference Stock S, Ignatiev K, Lee P, et al. Pathological calcification in juvenile dermatomyositis (JDM): microCT and synchrotron x-ray diffraction reveal hydroxyapatite with varied microstructures. Connect Tissue Res. 2004;45(4–5):248–56.CrossRefPubMed Stock S, Ignatiev K, Lee P, et al. Pathological calcification in juvenile dermatomyositis (JDM): microCT and synchrotron x-ray diffraction reveal hydroxyapatite with varied microstructures. Connect Tissue Res. 2004;45(4–5):248–56.CrossRefPubMed
12.
go back to reference Bohan A, Peter JB. Polymyositis and Dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.CrossRefPubMed Bohan A, Peter JB. Polymyositis and Dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.CrossRefPubMed
13.
go back to reference Toonen EJ, Barrera P, Fransen J, et al. Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis. Arthritis Res Ther. 2012;14(6):R264.CrossRefPubMedPubMedCentral Toonen EJ, Barrera P, Fransen J, et al. Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis. Arthritis Res Ther. 2012;14(6):R264.CrossRefPubMedPubMedCentral
14.
go back to reference Trieu EP, Targoff IN. Immunoprecipitation: Western blot for proteins of low abundance. Methods Mol Biol. 2015;1312:327–42.CrossRefPubMed Trieu EP, Targoff IN. Immunoprecipitation: Western blot for proteins of low abundance. Methods Mol Biol. 2015;1312:327–42.CrossRefPubMed
15.
go back to reference Rider LG, Shah M, Mamyrova G, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(4):223–43.CrossRef Rider LG, Shah M, Mamyrova G, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(4):223–43.CrossRef
16.
go back to reference Bode RK, Klein-Gitelman MS, Miller ML, et al. Disease activity scores for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum. 2003;49(1):7–15.CrossRefPubMed Bode RK, Klein-Gitelman MS, Miller ML, et al. Disease activity scores for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum. 2003;49(1):7–15.CrossRefPubMed
17.
go back to reference Huber AM, Feldman BM, Rennebohm RM, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004;50(5):1595–603.CrossRefPubMed Huber AM, Feldman BM, Rennebohm RM, et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004;50(5):1595–603.CrossRefPubMed
19.
go back to reference Deak PD, Smal Y, Kalender WA. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology. 2010;257(1):158–66.CrossRefPubMed Deak PD, Smal Y, Kalender WA. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology. 2010;257(1):158–66.CrossRefPubMed
20.
go back to reference Pachman LM, Liotta-Davis MR, Hong DK, et al TNF-alpha-308A allele in Juvenile Dermatomyositis: association with increased production of TNF-alpha, disease duration and pathological calcifications. Arthritis Rheum. 2000;43(10):2368–77.CrossRefPubMed Pachman LM, Liotta-Davis MR, Hong DK, et al TNF-alpha-308A allele in Juvenile Dermatomyositis: association with increased production of TNF-alpha, disease duration and pathological calcifications. Arthritis Rheum. 2000;43(10):2368–77.CrossRefPubMed
21.
go back to reference Rouster-Stevens KA, Morgan GA, Wang D, et al. Mycophenlate mofetil: a possible therapeutic agent for children with Juvenile Dermatomyositis. Arthritis Care Res (Hoboken). 2010;62(10):1446–51.CrossRef Rouster-Stevens KA, Morgan GA, Wang D, et al. Mycophenlate mofetil: a possible therapeutic agent for children with Juvenile Dermatomyositis. Arthritis Care Res (Hoboken). 2010;62(10):1446–51.CrossRef
22.
go back to reference Biswas D, Bible JE, Bohan M, et al. Radiation exposure from musculoskeletal computerized tomographic scans. J Bone Joint Surg Am. 2009;91(8):1882–9.CrossRefPubMed Biswas D, Bible JE, Bohan M, et al. Radiation exposure from musculoskeletal computerized tomographic scans. J Bone Joint Surg Am. 2009;91(8):1882–9.CrossRefPubMed
23.
go back to reference Eidelman N, Boyde A, BushbyAJ, et al. Microstructure and mineral composition of dystrophic calcifications associated with the idiopathic inflammatory myopathies. Arthrtis Res Ther. 2009;11(5):R159. doi:10.1186/ar2841 [published Online First: 25 Oct 2009]. Eidelman N, Boyde A, BushbyAJ, et al. Microstructure and mineral composition of dystrophic calcifications associated with the idiopathic inflammatory myopathies. Arthrtis Res Ther. 2009;11(5):R159. doi:10.​1186/​ar2841 [published Online First: 25 Oct 2009].
24.
go back to reference Pachman LM, Veis A, Stock S, et al. Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum. 2006;54(10):3345–50.CrossRefPubMedPubMedCentral Pachman LM, Veis A, Stock S, et al. Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum. 2006;54(10):3345–50.CrossRefPubMedPubMedCentral
25.
go back to reference Urganus AL, Zhao YD, Pachman LM. Juvenile dermatomyositis clacifications selectively displayed markers of bone formation. Arthritis Rheum. 2009;61(4):501–8.CrossRefPubMedPubMedCentral Urganus AL, Zhao YD, Pachman LM. Juvenile dermatomyositis clacifications selectively displayed markers of bone formation. Arthritis Rheum. 2009;61(4):501–8.CrossRefPubMedPubMedCentral
26.
go back to reference PachmanLM, Abbott K, Sinacore JM, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr. 2006;148(2):247–53. PachmanLM, Abbott K, Sinacore JM, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr. 2006;148(2):247–53.
27.
go back to reference Tansley SL, Betteridge ZE, Shaddick G, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford). 2014;53(12):2204–8. doi:10.1093/rheumatology/keu259 [published Online First: 1 Jul 2014].CrossRef Tansley SL, Betteridge ZE, Shaddick G, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford). 2014;53(12):2204–8. doi:10.​1093/​rheumatology/​keu259 [published Online First: 1 Jul 2014].CrossRef
30.
31.
go back to reference Hu S, Hoffman EA, Reinhardt JM. Automatic Lung Segmentation for accurate quanitation of volumetric x-ray CT images. IEEE Trans Med Imaging. 2001;20(6):490–8.CrossRefPubMed Hu S, Hoffman EA, Reinhardt JM. Automatic Lung Segmentation for accurate quanitation of volumetric x-ray CT images. IEEE Trans Med Imaging. 2001;20(6):490–8.CrossRefPubMed
Metadata
Title
Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography
Publication date
01-12-2016
Published in
Pediatric Rheumatology / Issue 1/2016
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-016-0123-3

Other articles of this Issue 1/2016

Pediatric Rheumatology 1/2016 Go to the issue